Bayer Cropscience Limited
Bayer Cropscience Limited (BAYERCROP): company summary
Annual revenue rose 3.7% to ₹5,675 crore, but the latest quarter revenue fell 4.2% to ₹1,835 crore compared to ₹1,915 crore a year earlier.
Bayer Cropscience Limited (BAYERCROP) is a small-cap Chemicals company valued at ₹16,360 crore operating in Pesticides & Agrochemicals on the NSE and BSE.
- Recent price move
- Bayer Cropscience Limited last traded at ₹3,638.4, modestly up 1.70% on the day.
- Recent developments
- On 2026-07-09, Bayer AG, a promoter entity, purchased 53,54,030 shares in Bayer CropScience Ltd, increasing its stake to 20.34% from 8.43%, as part of a ₹2,207 crore investment.
- Financial performance
- Annual revenue rose 3.7% to ₹5,675 crore, but the latest quarter revenue fell 4.2% to ₹1,835 crore compared to ₹1,915 crore a year earlier. Net profit rose 21.3% annually to ₹689 crore, while the latest quarter net profit rose 15.4% to ₹322 crore. The net profit margin improved by 1.8 percentage points to 12.1%, and return on equity remained at 23.2%.
- Valuation multiples
- The stock trades at 23.7 times earnings, 6.03 times book value. It yields 3.8%.
- Things to watch
- The latest quarter revenue fell 4.2% compared to the same quarter a year earlier. The stock is 31.0% below its 52-week high. Promoter holding remained at 71.43%, but domestic institutional holding decreased by 0.25 points in the quarter.
- Where it stands
- Bayer CropScience Ltd reported annual revenue growth of 3.7% and net profit growth of 21.3%, but the latest quarter revenue fell 4.2% compared to the same quarter a year earlier. The stock is 31.0% below its 52-week high, and the latest quarter net profit rose 15.4% to ₹322 crore.
Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Price performance
Supported by risk (9.3) and quality (7.9), but held back by momentum (0.0). Risk looks strong at 9.3, but that is offset by momentum at 0.0. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidenceAt a glance
Key highlights
- Low leverage — D/E 0.03
- Capital works hard — ROCE 29%
- Profitable in all of the last 5 years
- Momentum is weak (0.0/10)
- Near the bottom of its 52-week range (15%)
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Chemicals stocks · Pesticides & Agrochemicals
Explore Bayer Cropscience Limited’s valuation
Free deep-dive tools · no sign-up
Bayer Cropscience Limited peers in Chemicals
Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.
Related tools & concepts
Value Bayer Cropscience Limited with the ratios and calculators DocStoX uses in its analysis.

